Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein domain specific binding	NCOA2 NCOA3 PDCD6IP ATXN2 TJP1 LITAF PLSCR1 HGS TRPS1	8.53e-06	875	33	9	GO:0019904
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA2 NCOA3 ARID1B ARID1A SS18 GPS2	9.11e-06	303	33	6	GO:0003713
GeneOntologyMolecularFunction	protein-lysine 6-oxidase activity	LOXL1 LOXL2	2.64e-05	5	33	2	GO:0004720
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	NCOA2 NCOA3 SS18	1.39e-04	61	33	3	GO:0030374
GeneOntologyMolecularFunction	transcription coregulator activity	NCOA2 NCOA3 ARID1B ARID1A SS18 GPS2	2.81e-04	562	33	6	GO:0003712
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	LOXL1 LOXL2	3.13e-04	16	33	2	GO:0016641
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors	LOXL1 LOXL2	4.94e-04	20	33	2	GO:0016638
GeneOntologyMolecularFunction	molecular adaptor activity	NCOA2 NCOA3 ARID1B ARID1A SS18 TAB3 HGS GPS2	1.33e-03	1356	33	8	GO:0060090
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	NCOA2 NCOA3	1.44e-03	34	33	2	GO:0046966
GeneOntologyMolecularFunction	epidermal growth factor receptor binding	ATXN2 PLSCR1	2.09e-03	41	33	2	GO:0005154
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NCOA2 NCOA3 ARID1B ARID1A SS18 HGS GPS2	2.47e-03	1160	33	7	GO:0030674
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA2 NCOA3	3.46e-03	53	33	2	GO:0030331
GeneOntologyMolecularFunction	nuclear receptor binding	NCOA2 NCOA3 ARID1A	3.59e-03	187	33	3	GO:0016922
GeneOntologyBiologicalProcess	regulation of stem cell population maintenance	NCOA3 ARID1A SS18 LOXL2	7.12e-06	78	33	4	GO:2000036
GeneOntologyBiologicalProcess	peptidyl-lysine oxidation	LOXL1 LOXL2	2.47e-05	5	33	2	GO:0018057
GeneOntologyBiologicalProcess	positive regulation of stem cell population maintenance	NCOA3 ARID1A SS18	7.37e-05	51	33	3	GO:1902459
GeneOntologyBiologicalProcess	protein oxidation	LOXL1 LOXL2	2.23e-04	14	33	2	GO:0018158
GeneOntologyBiologicalProcess	nuclear receptor-mediated signaling pathway	NCOA2 NCOA3 ARID1A GPS2	2.92e-04	202	33	4	GO:0141193
GeneOntologyBiologicalProcess	positive regulation of exosomal secretion	PDCD6IP HGS	2.94e-04	16	33	2	GO:1903543
GeneOntologyBiologicalProcess	nuclear receptor-mediated glucocorticoid signaling pathway	NCOA2 ARID1A	3.33e-04	17	33	2	GO:0042921
GeneOntologyBiologicalProcess	positive regulation of intracellular steroid hormone receptor signaling pathway	NCOA2 NCOA3	3.74e-04	18	33	2	GO:0033145
GeneOntologyBiologicalProcess	nuclear receptor-mediated corticosteroid signaling pathway	NCOA2 ARID1A	3.74e-04	18	33	2	GO:0031958
GeneOntologyBiologicalProcess	regulation of exosomal secretion	PDCD6IP HGS	4.63e-04	20	33	2	GO:1903541
GeneOntologyBiologicalProcess	stem cell population maintenance	NCOA3 ARID1A SS18 LOXL2	5.35e-04	237	33	4	GO:0019827
GeneOntologyBiologicalProcess	negative regulation of developmental process	FOXJ2 NCOA3 ATXN2 SS18 LOXL2 HGS GPS2 STATH	5.38e-04	1220	33	8	GO:0051093
GeneOntologyBiologicalProcess	blood vessel development	FOXJ2 AMOTL2 ARID1A TJP1 LOXL1 LOXL2 HGS	5.62e-04	929	33	7	GO:0001568
GeneOntologyBiologicalProcess	maintenance of cell number	NCOA3 ARID1A SS18 LOXL2	5.79e-04	242	33	4	GO:0098727
GeneOntologyBiologicalProcess	response to mitochondrial depolarisation	VPS13C GPS2	6.15e-04	23	33	2	GO:0098780
GeneOntologyBiologicalProcess	vesicle localization	BSN PDCD6IP TFG HGS	6.25e-04	247	33	4	GO:0051648
GeneOntologyBiologicalProcess	exosomal secretion	PDCD6IP HGS	6.70e-04	24	33	2	GO:1990182
GeneOntologyBiologicalProcess	vasculature development	FOXJ2 AMOTL2 ARID1A TJP1 LOXL1 LOXL2 HGS	7.22e-04	969	33	7	GO:0001944
GeneOntologyBiologicalProcess	extracellular exosome biogenesis	PDCD6IP HGS	7.28e-04	25	33	2	GO:0097734
GeneOntologyBiologicalProcess	extracellular vesicle biogenesis	PDCD6IP HGS	8.50e-04	27	33	2	GO:0140112
GeneOntologyBiologicalProcess	peroxisome proliferator activated receptor signaling pathway	NCOA2 GPS2	9.14e-04	28	33	2	GO:0035357
GeneOntologyBiologicalProcess	regulation of nucleotide-excision repair	ARID1B ARID1A	9.81e-04	29	33	2	GO:2000819
GeneOntologyCellularComponent	npBAF complex	ARID1B ARID1A SS18	1.17e-06	14	32	3	GO:0071564
GeneOntologyCellularComponent	SWI/SNF complex	ARID1B ARID1A SS18	1.29e-05	30	32	3	GO:0016514
GeneOntologyCellularComponent	endoplasmic reticulum exit site	SEC31A PDCD6IP TFG	3.59e-05	42	32	3	GO:0070971
GeneOntologyCellularComponent	bBAF complex	ARID1B ARID1A	1.01e-04	10	32	2	GO:0140092
GeneOntologyCellularComponent	brahma complex	ARID1B ARID1A	2.04e-04	14	32	2	GO:0035060
GeneOntologyCellularComponent	nBAF complex	ARID1B ARID1A	2.69e-04	16	32	2	GO:0071565
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	ARID1B ARID1A SS18	4.23e-04	96	32	3	GO:0070603
GeneOntologyCellularComponent	cytoplasmic stress granule	ATXN2L CASC3 ATXN2	4.23e-04	96	32	3	GO:0010494
GeneOntologyCellularComponent	cytoplasmic ribonucleoprotein granule	ATXN2L CASC3 SNRPB2 ATXN2	7.26e-04	269	32	4	GO:0036464
GeneOntologyCellularComponent	nuclear protein-containing complex	NCOA2 CASC3 NCOA3 ARID1B ARID1A SNRPB2 SS18 DROSHA	8.79e-04	1377	32	8	GO:0140513
GeneOntologyCellularComponent	ribonucleoprotein granule	ATXN2L CASC3 SNRPB2 ATXN2	9.24e-04	287	32	4	GO:0035770
GeneOntologyCellularComponent	ATPase complex	ARID1B ARID1A SS18	9.99e-04	129	32	3	GO:1904949
GeneOntologyCellularComponent	bicellular tight junction	AMOTL2 PDCD6IP TJP1	1.04e-03	131	32	3	GO:0005923
GeneOntologyCellularComponent	tight junction	AMOTL2 PDCD6IP TJP1	1.24e-03	139	32	3	GO:0070160
GeneOntologyCellularComponent	chromatin	FOXJ2 NCOA2 NCOA3 ARID1B ARID1A SS18 LOXL2 TRPS1	1.40e-03	1480	32	8	GO:0000785
GeneOntologyCellularComponent	endosome	SEC31A AMOTL2 PDCD6IP LITAF VPS13C TAB3 HGS	1.63e-03	1167	32	7	GO:0005768
GeneOntologyCellularComponent	apical junction complex	AMOTL2 PDCD6IP TJP1	1.79e-03	158	32	3	GO:0043296
GeneOntologyCellularComponent	late endosome membrane	LITAF VPS13C HGS	2.55e-03	179	32	3	GO:0031902
Domain	LsmAD	ATXN2L ATXN2	3.03e-06	2	33	2	PF06741
Domain	BAF250_C	ARID1B ARID1A	3.03e-06	2	33	2	IPR033388
Domain	BAF250_C	ARID1B ARID1A	3.03e-06	2	33	2	PF12031
Domain	LsmAD_domain	ATXN2L ATXN2	3.03e-06	2	33	2	IPR009604
Domain	SM_dom_ATX	ATXN2L ATXN2	3.03e-06	2	33	2	IPR025852
Domain	SM-ATX	ATXN2L ATXN2	3.03e-06	2	33	2	PF14438
Domain	DUF4927	NCOA2 NCOA3	3.03e-06	2	33	2	PF16279
Domain	LsmAD	ATXN2L ATXN2	3.03e-06	2	33	2	SM01272
Domain	BAF250/Osa	ARID1B ARID1A	3.03e-06	2	33	2	IPR021906
Domain	DUF4927	NCOA2 NCOA3	3.03e-06	2	33	2	IPR032565
Domain	DUF1518	NCOA2 NCOA3	9.07e-06	3	33	2	PF07469
Domain	DUF1518	NCOA2 NCOA3	9.07e-06	3	33	2	IPR010011
Domain	Src1_rcpt_coact	NCOA2 NCOA3	9.07e-06	3	33	2	IPR008955
Domain	Nuclear_rcpt_coactivator	NCOA2 NCOA3	9.07e-06	3	33	2	IPR017426
Domain	DUF1518	NCOA2 NCOA3	9.07e-06	3	33	2	SM01151
Domain	Nuc_rcpt_coact_Ncoa-typ	NCOA2 NCOA3	9.07e-06	3	33	2	IPR014920
Domain	SRC-1	NCOA2 NCOA3	9.07e-06	3	33	2	IPR014935
Domain	SRC-1	NCOA2 NCOA3	9.07e-06	3	33	2	PF08832
Domain	-	NCOA2 NCOA3	9.07e-06	3	33	2	4.10.630.10
Domain	Nuc_rec_co-act	NCOA2 NCOA3	9.07e-06	3	33	2	PF08815
Domain	Lysyl_oxidase	LOXL1 LOXL2	3.02e-05	5	33	2	IPR001695
Domain	Lysyl_oxidase_CS	LOXL1 LOXL2	3.02e-05	5	33	2	IPR019828
Domain	LYSYL_OXIDASE	LOXL1 LOXL2	3.02e-05	5	33	2	PS00926
Domain	Lysyl_oxidase	LOXL1 LOXL2	3.02e-05	5	33	2	PF01186
Domain	Nuc_rcpt_coact	NCOA2 NCOA3	4.52e-05	6	33	2	IPR009110
Domain	PAM2	ATXN2L ATXN2	1.08e-04	9	33	2	PF07145
Domain	Ataxin-2_C	ATXN2L ATXN2	1.08e-04	9	33	2	IPR009818
Domain	-	ARID1B ARID1A	3.13e-04	15	33	2	1.10.150.60
Domain	ARID	ARID1B ARID1A	3.13e-04	15	33	2	PF01388
Domain	BRIGHT	ARID1B ARID1A	3.13e-04	15	33	2	SM00501
Domain	ARID_dom	ARID1B ARID1A	3.13e-04	15	33	2	IPR001606
Domain	ARID	ARID1B ARID1A	3.13e-04	15	33	2	PS51011
Domain	PAS	NCOA2 NCOA3	8.85e-04	25	33	2	PF00989
Domain	PAS_fold	NCOA2 NCOA3	8.85e-04	25	33	2	IPR013767
Domain	PAS	NCOA2 NCOA3	1.45e-03	32	33	2	SM00091
Domain	PAS	NCOA2 NCOA3	1.64e-03	34	33	2	IPR000014
Domain	PAS	NCOA2 NCOA3	1.64e-03	34	33	2	PS50112
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION	ARID1B ARID1A SS18	5.40e-05	42	25	3	M48237
Pathway	KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY	NCOA2 NCOA3	1.64e-04	11	25	2	M47503
Pathway	WP_EGFEGFR_SIGNALING	NCOA3 ATXN2 PLSCR1 HGS	1.76e-04	162	25	4	M39334
Pathway	PID_ERB_GENOMIC_PATHWAY	NCOA2 NCOA3	3.13e-04	15	25	2	M119
Pathway	WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING	LOXL1 LOXL2	4.04e-04	17	25	2	M39686
Pathway	WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS	PDCD6IP HGS	4.54e-04	18	25	2	M39737
Pathway	REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS	LOXL1 LOXL2	4.54e-04	18	25	2	M27164
Pathway	REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS	LOXL1 LOXL2	4.54e-04	18	25	2	MM14882
Pathway	REACTOME_SIGNALING_BY_HIPPO	AMOTL2 TJP1	5.63e-04	20	25	2	MM14813
Pathway	REACTOME_SIGNALING_BY_HIPPO	AMOTL2 TJP1	5.63e-04	20	25	2	M591
Pathway	REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION	ARID1B ARID1A SS18	6.12e-04	95	25	3	M48268
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS	ARID1B ARID1A SS18	6.51e-04	97	25	3	M48262
Pathway	BIOCARTA_VDR_PATHWAY	NCOA3 ARID1A	6.82e-04	22	25	2	MM1370
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA2 NCOA3 GPS2	1.15e-03	118	25	3	M27316
Pathway	WP_KLEEFSTRA_SYNDROME	ARID1B ARID1A	1.19e-03	29	25	2	M48076
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	NCOA2 ARID1B ARID1A GPS2	1.25e-03	272	25	4	M29619
Pathway	PID_RETINOIC_ACID_PATHWAY	NCOA2 NCOA3	1.27e-03	30	25	2	M207
Pathway	WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1	ARID1B ARID1A	1.36e-03	31	25	2	M39522
Pathway	WP_PREGNANE_X_RECEPTOR_PATHWAY	NCOA2 NCOA3	1.45e-03	32	25	2	M39567
Pathway	KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY	ARID1B ARID1A	1.73e-03	35	25	2	M47969
Pathway	REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT	ARID1B ARID1A SS18	1.77e-03	137	25	3	M48232
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	ARID1B ARID1A	1.94e-03	37	25	2	M27797
Pathway	REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS	ARID1B ARID1A SS18	1.96e-03	142	25	3	M48257
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	LOXL1 LOXL2	2.15e-03	39	25	2	MM14601
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	LOXL1 LOXL2	2.73e-03	44	25	2	M26969
Pubmed	Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor.	ARID1B SEC31A PDCD6IP ARID1A TFG	1.15e-09	50	33	5	27716508
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA2 NCOA3 ARID1B ARID1A ZC3H4 GPS2 TRPS1	5.37e-09	268	33	7	33640491
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	NCOA2 ATXN2L NCOA3 R3HDM2 TAB3 GPS2	6.34e-09	152	33	6	38360978
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	NCOA2 ATXN2L CASC3 ARID1B TSC22D2 AMOTL2 PDCD6IP TFG ATXN2 ZC3H4	8.70e-09	922	33	10	27609421
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA2 NCOA3 ARID1B ARID1A TRPS1	1.54e-08	83	33	5	28794006
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	CASC3 AMOTL2 ARID1A SS18 ZC3H4 LOXL2 TRPS1	2.34e-08	332	33	7	37433992
Pubmed	Proline-rich sequence recognition: II. Proteomics analysis of Tsg101 ubiquitin-E2-like variant (UEV) interactions.	PDCD6IP TFG ATXN2 HGS	2.37e-08	32	33	4	19542561
Pubmed	Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.	ARID1B ARID1A SS18	2.72e-08	7	33	3	23540691
Pubmed	Human transcription factor protein interaction networks.	NCOA2 NCOA3 R3HDM2 ARID1B ARID1A ATXN2 SS18 TAB3 HGS GPS2 TRPS1	4.56e-08	1429	33	11	35140242
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	ATXN2L ARID1B AMOTL2 ARID1A SNRPB2 ATXN2 TJP1 DROSHA	8.59e-08	615	33	8	31048545
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA2 NCOA3 ARID1B BSN PDCD6IP ARID1A SS18 TRPS1	1.14e-07	638	33	8	31182584
Pubmed	Ubiquitin-specific protease 8 deubiquitinates Sec31A and decreases large COPII carriers and collagen IV secretion.	SEC31A PDCD6IP HGS	1.28e-07	11	33	3	29604273
Pubmed	SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones.	ARID1B ARID1A SS18	1.70e-07	12	33	3	11734557
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOA2 CASC3 NCOA3 SEC31A BSN PDCD6IP ATXN2 TJP1 ZC3H4	1.96e-07	963	33	9	28671696
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	ARID1B SEC31A PDCD6IP ARID1A TFG ZC3H4 HGS	2.55e-07	472	33	7	38943005
Pubmed	Kinetic analysis of npBAF to nBAF switching reveals exchange of SS18 with CREST and integration with neural developmental pathways.	ARID1B ARID1A SS18	3.51e-07	15	33	3	23785148
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 ATXN2L ARID1B AMOTL2 ARID1A TJP1 TAB3	7.04e-07	549	33	7	38280479
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NCOA2 CASC3 PDCD6IP ARID1A ATXN2 TJP1 NDUFB8 VPS13C LOXL2 TRPS1	7.54e-07	1489	33	10	28611215
Pubmed	Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis.	ARID1B ARID1A	8.73e-07	2	33	2	37611161
Pubmed	Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.	ARID1B ARID1A	8.73e-07	2	33	2	32791957
Pubmed	Dual ARID1A/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes.	ARID1B ARID1A	8.73e-07	2	33	2	34386776
Pubmed	ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.	ARID1B ARID1A	8.73e-07	2	33	2	29890703
Pubmed	Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.	ARID1B ARID1A	8.73e-07	2	33	2	23202128
Pubmed	A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells.	NCOA2 NCOA3	8.73e-07	2	33	2	30048685
Pubmed	ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics.	ARID1B ARID1A	8.73e-07	2	33	2	33890484
Pubmed	SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.	ARID1B ARID1A	8.73e-07	2	33	2	24788099
Pubmed	Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis.	NCOA2 NCOA3	8.73e-07	2	33	2	21220509
Pubmed	Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.	ARID1B ARID1A	8.73e-07	2	33	2	28967863
Pubmed	Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Distinct Entity Characterized by Recurrent NCOA2/3 Gene Fusions.	NCOA2 NCOA3	8.73e-07	2	33	2	30273195
Pubmed	Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.	ARID1B ARID1A	8.73e-07	2	33	2	33052929
Pubmed	ARID1B is a specific vulnerability in ARID1A-mutant cancers.	ARID1B ARID1A	8.73e-07	2	33	2	24562383
Pubmed	Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2.	ATXN2L ATXN2	8.73e-07	2	33	2	8896555
Pubmed	Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.	LOXL1 LOXL2	8.73e-07	2	33	2	29125826
Pubmed	Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.	ARID1B ARID1A	8.73e-07	2	33	2	27562491
Pubmed	Effects of a Levonorgestrel-Releasing Intrauterine System on the Expression of Steroid Receptor Coregulators in Adenomyosis.	NCOA2 NCOA3	8.73e-07	2	33	2	26040939
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA2 NCOA3 ARID1B ARID1A GPS2 TRPS1	8.91e-07	351	33	6	38297188
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	NCOA2 NCOA3 ARID1B ARID1A	9.12e-07	78	33	4	28611094
Pubmed	FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.	ARID1B ARID1A SS18	1.36e-06	23	33	3	30962207
Pubmed	A protein interaction landscape of breast cancer.	ARID1B SEC31A AMOTL2 ARID1A SS18 LOXL2 HGS	1.83e-06	634	33	7	34591612
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	NCOA2 NCOA3 ARID1B PDCD6IP ARID1A TRPS1	1.84e-06	398	33	6	35016035
Pubmed	Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.	ARID1B ARID1A SS18	2.24e-06	27	33	3	29374058
Pubmed	Eda-activated RelB recruits an SWI/SNF (BAF) chromatin-remodeling complex and initiates gene transcription in skin appendage formation.	ARID1B ARID1A TFG	2.51e-06	28	33	3	30037996
Pubmed	Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.	ARID1B ARID1A	2.62e-06	3	33	2	33432679
Pubmed	The copper dependent-lysyl oxidases contribute to the pathogenesis of pulmonary emphysema in chronic obstructive pulmonary disease patients.	LOXL1 LOXL2	2.62e-06	3	33	2	28965583
Pubmed	The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles.	NCOA2 NCOA3	2.62e-06	3	33	2	21035760
Pubmed	Ataxin-2-like is a regulator of stress granules and processing bodies.	ATXN2L ATXN2	2.62e-06	3	33	2	23209657
Pubmed	Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.	NCOA2 NCOA3	2.62e-06	3	33	2	18845648
Pubmed	Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle.	ARID1B ARID1A	2.62e-06	3	33	2	21647563
Pubmed	The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP.	NCOA2 NCOA3	2.62e-06	3	33	2	12138202
Pubmed	Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.	NCOA2 NCOA3	2.62e-06	3	33	2	21059860
Pubmed	Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome.	ARID1B ARID1A	2.62e-06	3	33	2	22426308
Pubmed	The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms.	LOXL1 LOXL2	2.62e-06	3	33	2	23494965
Pubmed	Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.	ARID1B ARID1A	2.62e-06	3	33	2	24382590
Pubmed	Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis.	NCOA2 NCOA3	2.62e-06	3	33	2	21735116
Pubmed	Absence of the steroid receptor coactivator-3 induces B-cell lymphoma.	NCOA2 NCOA3	2.62e-06	3	33	2	16675958
Pubmed	TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer.	ARID1B ARID1A	2.62e-06	3	33	2	34044070
Pubmed	Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes.	ARID1B ARID1A	2.62e-06	3	33	2	26716708
Pubmed	The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1.	NCOA2 NCOA3	2.62e-06	3	33	2	11923473
Pubmed	FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors.	NCOA2 NCOA3	2.62e-06	3	33	2	15698540
Pubmed	Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.	NCOA2 NCOA3	2.62e-06	3	33	2	9506940
Pubmed	Structure and chromosomal locations of mouse steroid receptor coactivator gene family.	NCOA2 NCOA3	2.62e-06	3	33	2	10501088
Pubmed	Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.	NCOA2 NCOA3	2.62e-06	3	33	2	28390937
Pubmed	ALG-2 directly binds Sec31A and localizes at endoplasmic reticulum exit sites in a Ca2+-dependent manner.	SEC31A PDCD6IP	2.62e-06	3	33	2	17196169
Pubmed	Estrogen signaling in colorectal carcinoma microenvironment: expression of ERbeta1, AIB-1, and TIF-2 is upregulated in cancer-associated myofibroblasts and correlates with disease progression.	NCOA2 NCOA3	2.62e-06	3	33	2	19277704
Pubmed	Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences.	NCOA2 NCOA3	2.62e-06	3	33	2	23927929
Pubmed	Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation.	NCOA2 NCOA3	2.62e-06	3	33	2	19052561
Pubmed	Structural analysis of the complex between penta-EF-hand ALG-2 protein and Sec31A peptide reveals a novel target recognition mechanism of ALG-2.	SEC31A PDCD6IP	2.62e-06	3	33	2	25667979
Pubmed	The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism.	NCOA2 NCOA3	2.62e-06	3	33	2	16423883
Pubmed	ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer.	ARID1B ARID1A	2.62e-06	3	33	2	34512623
Pubmed	RNF138 inhibits late inflammatory gene transcription through degradation of SMARCC1 of the SWI/SNF complex.	ATXN2L ARID1B ARID1A	2.80e-06	29	33	3	36800290
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	R3HDM2 ARID1B AMOTL2 ARID1A TJP1 HGS	3.55e-06	446	33	6	24255178
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOA2 NCOA3 ARID1B ARID1A TFG ATXN2	4.08e-06	457	33	6	32344865
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	CASC3 NCOA3 SEC31A AMOTL2 SNRPB2 TJP1 DROSHA GPS2	4.38e-06	1038	33	8	26673895
Pubmed	Global proteomics of Ubqln2-based murine models of ALS.	PDCD6IP TFG SS18 TAB3 HGS	4.58e-06	261	33	5	33277362
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ARID1A ATXN2 TJP1 TAB3 HGS	4.75e-06	263	33	5	34702444
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ATXN2L CASC3 ARID1B TFG TJP1 VPS13C HGS	4.76e-06	733	33	7	34672954
Pubmed	miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.	NCOA2 NCOA3	5.23e-06	4	33	2	26066330
Pubmed	Differential expression of the LOX family genes in human colorectal adenocarcinomas.	LOXL1 LOXL2	5.23e-06	4	33	2	19724858
Pubmed	Inactivating mutations in Drosha mediate vascular abnormalities similar to hereditary hemorrhagic telangiectasia.	TJP1 DROSHA	5.23e-06	4	33	2	29339534
Pubmed	Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.	NCOA2 NCOA3	5.23e-06	4	33	2	12893883
Pubmed	Lysyl oxidases: a novel multifunctional amine oxidase family.	LOXL1 LOXL2	5.23e-06	4	33	2	11642359
Pubmed	Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance?	NCOA2 NCOA3	5.23e-06	4	33	2	19198856
Pubmed	Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy.	NCOA2 NCOA3	5.23e-06	4	33	2	22560224
Pubmed	Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules.	ATXN2L ATXN2	5.23e-06	4	33	2	17392519
Pubmed	Undifferentiated Endometrial Carcinomas Show Frequent Loss of Core Switch/Sucrose Nonfermentable Complex Proteins.	ARID1B ARID1A	5.23e-06	4	33	2	28863077
Pubmed	P160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain.	NCOA2 NCOA3	5.23e-06	4	33	2	18267973
Pubmed	Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells.	NCOA2 NCOA3	5.23e-06	4	33	2	15331759
Pubmed	Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2.	NCOA2 NCOA3	5.23e-06	4	33	2	10598588
Pubmed	Structural and functional diversity of lysyl oxidase and the LOX-like proteins.	LOXL1 LOXL2	5.23e-06	4	33	2	12686136
Pubmed	Interactions of RXR with coactivators are differentially mediated by helix 11 of the receptor's ligand binding domain.	NCOA2 NCOA3	5.23e-06	4	33	2	11851396
Pubmed	Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.	NCOA2 NCOA3	5.23e-06	4	33	2	26267537
Pubmed	Two related ARID family proteins are alternative subunits of human SWI/SNF complexes.	ARID1B ARID1A	5.23e-06	4	33	2	15170388
Pubmed	Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein.	ARID1B ARID1A	5.23e-06	4	33	2	11988099
Pubmed	Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells.	NCOA2 NCOA3	5.23e-06	4	33	2	19462000
Pubmed	Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.	NCOA2 NCOA3	5.23e-06	4	33	2	19095746
Pubmed	Ultrastructural analysis of ESCRT proteins suggests a role for endosome-associated tubular-vesicular membranes in ESCRT function.	PDCD6IP HGS	5.23e-06	4	33	2	17014699
Pubmed	The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.	NCOA2 NCOA3	5.23e-06	4	33	2	15563469
Pubmed	Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD.	NCOA2 NCOA3	5.23e-06	4	33	2	15563453
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ARID1B SEC31A PDCD6IP ARID1A SNRPB2 TJP1 ZC3H4 DROSHA	5.94e-06	1082	33	8	38697112
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA2 ATXN2L NCOA3 ARID1B ARID1A SNRPB2 ATXN2 GPS2	6.84e-06	1103	33	8	34189442
Interaction	SOX17 interactions	NCOA2 NCOA3 ARID1B ARID1A SS18 GPS2 TRPS1	1.60e-10	95	33	7	int:SOX17
Interaction	TBXT interactions	NCOA2 NCOA3 ARID1B ARID1A SS18 GPS2 TRPS1	6.58e-10	116	33	7	int:TBXT
Interaction	FAM168A interactions	R3HDM2 ARID1B AMOTL2 TFG TJP1 PLSCR1 HGS	2.72e-09	142	33	7	int:FAM168A
Interaction	WWP2 interactions	ATXN2L ARID1B AMOTL2 PDCD6IP ARID1A SNRPB2 ATXN2 TJP1 LITAF DROSHA TAB3 HGS	4.02e-09	840	33	12	int:WWP2
Interaction	SOX10 interactions	NCOA2 NCOA3 ARID1B ARID1A GPS2 TRPS1	7.69e-09	92	33	6	int:SOX10
Interaction	PAX8 interactions	NCOA2 NCOA3 ARID1B ARID1A GPS2 TRPS1	2.39e-08	111	33	6	int:PAX8
Interaction	SMG7 interactions	NCOA2 NCOA3 R3HDM2 ARID1B ARID1A ATXN2 ZC3H4 TRPS1	3.55e-08	319	33	8	int:SMG7
Interaction	PAX7 interactions	NCOA3 ARID1B ARID1A SS18 GPS2 TRPS1	4.64e-08	124	33	6	int:PAX7
Interaction	PAX9 interactions	NCOA2 NCOA3 ARID1B ARID1A GPS2 TRPS1	6.16e-08	130	33	6	int:PAX9
Interaction	ETV4 interactions	NCOA2 NCOA3 ARID1B ARID1A SS18	8.94e-08	69	33	5	int:ETV4
Interaction	SOX15 interactions	NCOA2 NCOA3 ARID1B ARID1A GPS2 TRPS1	9.99e-08	141	33	6	int:SOX15
Interaction	MYCN interactions	ATXN2L CASC3 ARID1B SEC31A AMOTL2 ARID1A SNRPB2 TFG ATXN2 SS18 ZC3H4 VPS13C LOXL1	1.02e-07	1373	33	13	int:MYCN
Interaction	EYA4 interactions	FOXJ2 NCOA2 ATXN2L NCOA3 R3HDM2 TAB3 GPS2	1.11e-07	243	33	7	int:EYA4
Interaction	MEX3A interactions	CASC3 R3HDM2 AMOTL2 ARID1A SS18 ZC3H4 LOXL2 TRPS1	1.48e-07	384	33	8	int:MEX3A
Interaction	CRX interactions	NCOA2 NCOA3 ARID1B ARID1A TFG HGS TRPS1	1.50e-07	254	33	7	int:CRX
Interaction	SOX7 interactions	NCOA2 NCOA3 ARID1B ARID1A TRPS1	2.14e-07	82	33	5	int:SOX7
Interaction	HNF4A interactions	NCOA2 NCOA3 ARID1B ARID1A SS18 GPS2 TRPS1	2.57e-07	275	33	7	int:HNF4A
Interaction	FOXI1 interactions	NCOA3 ARID1B ARID1A HGS TRPS1	3.81e-07	92	33	5	int:FOXI1
Interaction	ALG13 interactions	NCOA2 NCOA3 R3HDM2 ARID1B ARID1A ATXN2	4.67e-07	183	33	6	int:ALG13
Interaction	SP7 interactions	NCOA2 NCOA3 ARID1B ARID1A SS18 GPS2 TRPS1	5.06e-07	304	33	7	int:SP7
Interaction	NFIA interactions	NCOA2 NCOA3 ARID1B ARID1A GPS2 TRPS1	5.47e-07	188	33	6	int:NFIA
Interaction	HNF1B interactions	NCOA2 NCOA3 ARID1B ARID1A GPS2 TRPS1	5.81e-07	190	33	6	int:HNF1B
Interaction	MYOD1 interactions	NCOA2 NCOA3 ARID1B ARID1A SS18 TRPS1	6.57e-07	194	33	6	int:MYOD1
Interaction	KLF5 interactions	NCOA2 NCOA3 ARID1B ARID1A SS18 TRPS1	6.77e-07	195	33	6	int:KLF5
Interaction	PDCD6 interactions	ARID1B SEC31A PDCD6IP ARID1A TFG DROSHA	8.81e-07	204	33	6	int:PDCD6
Interaction	TBR1 interactions	NCOA2 NCOA3 ARID1B ARID1A TRPS1	1.06e-06	113	33	5	int:TBR1
Interaction	MCRIP2 interactions	ATXN2L CASC3 R3HDM2 ATXN2	1.41e-06	51	33	4	int:MCRIP2
Interaction	ERG interactions	NCOA2 NCOA3 ARID1B ARID1A SS18 TRPS1	1.48e-06	223	33	6	int:ERG
Interaction	EYA2 interactions	ARID1B ARID1A TFG HGS TRPS1	1.49e-06	121	33	5	int:EYA2
Interaction	TNIP2 interactions	NCOA2 ATXN2L CASC3 ARID1B TSC22D2 AMOTL2 PDCD6IP TFG ATXN2 ZC3H4	1.81e-06	952	33	10	int:TNIP2
Interaction	TPRX2 interactions	NCOA2 ARID1B ARID1A GPS2	2.06e-06	56	33	4	int:TPRX2
Interaction	TLE3 interactions	FOXJ2 NCOA2 NCOA3 ARID1B ARID1A GPS2 TRPS1	2.09e-06	376	33	7	int:TLE3
Interaction	VPS37C interactions	PDCD6IP TFG PLSCR1 HGS GPS2	3.16e-06	141	33	5	int:VPS37C
Interaction	TFG interactions	R3HDM2 SEC31A PDCD6IP TFG PLSCR1 HGS	3.44e-06	258	33	6	int:TFG
Interaction	WWTR1 interactions	NCOA2 ATXN2L ARID1B AMOTL2 ARID1A TJP1 TAB3	4.48e-06	422	33	7	int:WWTR1
Interaction	GCM1 interactions	NCOA3 ARID1B ARID1A SS18	4.51e-06	68	33	4	int:GCM1
Interaction	NUP35 interactions	NCOA2 NCOA3 ARID1B PDCD6IP ARID1A TFG ATXN2	4.62e-06	424	33	7	int:NUP35
Interaction	SMARCE1 interactions	NCOA2 NCOA3 ARID1B AMOTL2 ARID1A SS18	6.35e-06	287	33	6	int:SMARCE1
Interaction	LHX4 interactions	NCOA2 ARID1B ARID1A GPS2 TRPS1	7.03e-06	166	33	5	int:LHX4
Interaction	EGR2 interactions	NCOA2 NCOA3 ARID1B ARID1A TRPS1	8.12e-06	171	33	5	int:EGR2
Interaction	EP300 interactions	NCOA2 CASC3 NCOA3 SEC31A BSN ARID1A SNRPB2 SS18 ZC3H4 PLSCR1 GPS2	8.18e-06	1401	33	11	int:EP300
Interaction	RNF4 interactions	FOXJ2 ATXN2L ARID1B TFG ATXN2 TJP1 NDUFB8 PLSCR1 TAB3 HGS TRPS1	8.81e-06	1412	33	11	int:RNF4
Interaction	TLX1 interactions	NCOA2 NCOA3 ARID1B ARID1A TRPS1	9.09e-06	175	33	5	int:TLX1
Interaction	SOX2 interactions	NCOA2 ATXN2L NCOA3 ARID1B AMOTL2 ARID1A SNRPB2 SS18 LOXL1 GPS2 TRPS1	9.43e-06	1422	33	11	int:SOX2
Interaction	PAX2 interactions	NCOA3 ARID1B GPS2 TRPS1	1.10e-05	85	33	4	int:PAX2
Interaction	IRF4 interactions	NCOA3 ARID1B ARID1A SS18	1.10e-05	85	33	4	int:IRF4
Interaction	DAZAP2 interactions	TFG LITAF PLSCR1 HGS GPS2	1.22e-05	186	33	5	int:DAZAP2
Interaction	CARM1 interactions	NCOA2 NCOA3 SEC31A PDCD6IP ARID1A DROSHA	1.29e-05	325	33	6	int:CARM1
Interaction	GATA2 interactions	NCOA3 ARID1B ARID1A SS18 TRPS1	1.69e-05	199	33	5	int:GATA2
Interaction	SOX9 interactions	NCOA3 ARID1B ARID1A TRPS1	1.85e-05	97	33	4	int:SOX9
Interaction	FEV interactions	NCOA2 NCOA3 ARID1B ARID1A TRPS1	1.86e-05	203	33	5	int:FEV
Interaction	NR3C1 interactions	FOXJ2 NCOA2 NCOA3 ARID1B BSN PDCD6IP ARID1A SS18 TRPS1	1.87e-05	974	33	9	int:NR3C1
Interaction	SS18L1 interactions	ARID1B ARID1A SS18 HGS	1.93e-05	98	33	4	int:SS18L1
Interaction	FMR1 interactions	NCOA2 ATXN2L CASC3 NCOA3 BSN ATXN2 TJP1	2.12e-05	536	33	7	int:FMR1
Interaction	AR interactions	NCOA2 NCOA3 ARID1B ARID1A TJP1 ZC3H4 VPS13C GPS2 TRPS1	2.16e-05	992	33	9	int:AR
Interaction	TRIM68 interactions	TFG TJP1 LOXL1 GPS2	2.17e-05	101	33	4	int:TRIM68
Interaction	NFIC interactions	NCOA3 ARID1B ARID1A GPS2 TRPS1	2.19e-05	210	33	5	int:NFIC
Interaction	PAX6 interactions	NCOA3 ARID1B ARID1A HGS GPS2 TRPS1	2.52e-05	366	33	6	int:PAX6
Interaction	PEF1 interactions	SEC31A PDCD6IP TFG HGS	2.83e-05	108	33	4	int:PEF1
Interaction	THRA interactions	NCOA2 NCOA3 AMOTL2 GPS2	3.15e-05	111	33	4	int:THRA
Interaction	KLF3 interactions	ARID1B ARID1A SS18 GPS2 TRPS1	3.25e-05	228	33	5	int:KLF3
Interaction	NR5A2 interactions	NCOA2 NCOA3 GPS2	4.09e-05	41	33	3	int:NR5A2
Interaction	DDIT3 interactions	ARID1B AMOTL2 ARID1A SS18	4.28e-05	120	33	4	int:DDIT3
Interaction	ETS1 interactions	NCOA3 ARID1B ARID1A TRPS1	4.42e-05	121	33	4	int:ETS1
Interaction	YWHAH interactions	NCOA2 ATXN2L CASC3 NCOA3 R3HDM2 AMOTL2 PDCD6IP TJP1 TAB3	4.95e-05	1102	33	9	int:YWHAH
Interaction	R3HDM2 interactions	CASC3 R3HDM2 TFG ATXN2	5.68e-05	129	33	4	int:R3HDM2
Interaction	PPIA interactions	ARID1B SEC31A PDCD6IP ARID1A TFG ZC3H4 LOXL2 HGS	7.15e-05	888	33	8	int:PPIA
Interaction	NFIB interactions	NCOA3 ARID1B ARID1A TRPS1	8.25e-05	142	33	4	int:NFIB
Interaction	DAZL interactions	ATXN2L CASC3 R3HDM2 ATXN2	8.94e-05	145	33	4	int:DAZL
Interaction	SUMO1 interactions	NCOA2 NCOA3 TJP1 HGS TRPS1	9.68e-05	287	33	5	int:SUMO1
Interaction	PRMT1 interactions	NCOA2 ATXN2L NCOA3 SNRPB2 TFG ATXN2 ZC3H4 TAB3	9.81e-05	929	33	8	int:PRMT1
Interaction	TLX3 interactions	NCOA2 NCOA3 ARID1B ARID1A TRPS1	1.03e-04	291	33	5	int:TLX3
Interaction	POU2AF1 interactions	TFG HGS GPS2	1.05e-04	56	33	3	int:POU2AF1
Interaction	ARID2 interactions	ARID1B TSC22D2 ARID1A SS18	1.10e-04	153	33	4	int:ARID2
Interaction	TSG101 interactions	PDCD6IP TFG ATXN2 LITAF HGS	1.25e-04	303	33	5	int:TSG101
Interaction	SAP18 interactions	CASC3 NCOA3 TSC22D2 ARID1A SNRPB2	1.29e-04	305	33	5	int:SAP18
Interaction	KLF4 interactions	NCOA3 ARID1B ARID1A HGS	1.31e-04	160	33	4	int:KLF4
Interaction	PPARG interactions	NCOA2 NCOA3 ARID1B GPS2 TRPS1	1.33e-04	307	33	5	int:PPARG
Interaction	PTPN23 interactions	ATXN2L PDCD6IP ATXN2 HGS	1.37e-04	162	33	4	int:PTPN23
Interaction	FLI1 interactions	ARID1B ARID1A SS18	1.42e-04	62	33	3	int:FLI1
Interaction	FOS interactions	NCOA2 NCOA3 ARID1B ARID1A SS18	1.43e-04	312	33	5	int:FOS
Interaction	LSM12 interactions	ATXN2L CASC3 R3HDM2 ATXN2	1.44e-04	164	33	4	int:LSM12
Interaction	MECP2 interactions	ATXN2L ARID1B SEC31A PDCD6IP ARID1A SNRPB2 TJP1 ZC3H4 DROSHA	1.64e-04	1287	33	9	int:MECP2
Interaction	MAP3K7CL interactions	TAB3 GPS2	1.70e-04	12	33	2	int:MAP3K7CL
Interaction	BICRA interactions	ARID1B ARID1A SS18	1.78e-04	67	33	3	int:BICRA
Interaction	ARID1B interactions	NCOA3 ARID1B ARID1A SS18	1.93e-04	177	33	4	int:ARID1B
Interaction	TP53BP1 interactions	NCOA3 ARID1B ARID1A ZC3H4 HGS TRPS1	2.01e-04	533	33	6	int:TP53BP1
Interaction	ATXN1 interactions	ATXN2L R3HDM2 SEC31A PDCD6IP ARID1A ATXN2 LITAF LOXL1	2.13e-04	1039	33	8	int:ATXN1
Interaction	LHX2 interactions	ARID1B ARID1A SS18 TRPS1	2.19e-04	183	33	4	int:LHX2
Interaction	NEDD4 interactions	AMOTL2 PDCD6IP ARID1A LITAF PLSCR1 HGS	2.24e-04	544	33	6	int:NEDD4
Interaction	ATG5 interactions	BSN ATXN2 TJP1 VPS13C TAB3	2.26e-04	344	33	5	int:ATG5
Interaction	THRB interactions	NCOA2 NCOA3 BSN GPS2	2.33e-04	186	33	4	int:THRB
Interaction	GATA3 interactions	NCOA3 ARID1B ARID1A TRPS1	2.38e-04	187	33	4	int:GATA3
Interaction	CELA2A interactions	PDCD6IP HGS	3.08e-04	16	33	2	int:CELA2A
Interaction	FOXJ2 interactions	FOXJ2 NCOA2 TRPS1	3.13e-04	81	33	3	int:FOXJ2
Interaction	KHDRBS1 interactions	ATXN2L ATXN2 TJP1 DROSHA LOXL2	3.28e-04	373	33	5	int:KHDRBS1
Interaction	STK11IP interactions	ARID1B ARID1A SS18	3.36e-04	83	33	3	int:STK11IP
Interaction	NR0B2 interactions	NCOA3 PLSCR1 GPS2	3.36e-04	83	33	3	int:NR0B2
Interaction	IRF1 interactions	ARID1B ARID1A SS18	3.36e-04	83	33	3	int:IRF1
Interaction	R3HDM1 interactions	R3HDM2 ATXN2 LITAF	3.48e-04	84	33	3	int:R3HDM1
GeneFamily	AT-rich interaction domain containing	ARID1B ARID1A	9.75e-05	15	18	2	418
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA2 NCOA3	1.26e-04	17	18	2	486
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOA3 ATXN2	2.77e-04	25	18	2	775
GeneFamily	Basic helix-loop-helix proteins	NCOA2 NCOA3	5.27e-03	110	18	2	420
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP	ATXN2L TJP1 ZC3H4 LITAF GPS2	4.79e-06	199	33	5	M5203
Coexpression	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	FOXJ2 NCOA3 PDCD6IP TFG LITAF	6.37e-05	341	33	5	M12636
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOA2 NCOA3 R3HDM2 TSC22D2 ATXN2 ZC3H4 PLSCR1	7.86e-05	856	33	7	M4500
Coexpression	DELACROIX_RARG_BOUND_MEF	ATXN2 NDUFB8 PLSCR1 LOXL1 LOXL2	8.89e-05	366	33	5	M2461
Coexpression	DELACROIX_RARG_BOUND_MEF	ATXN2 NDUFB8 PLSCR1 LOXL1 LOXL2	1.03e-04	378	33	5	MM1077
Coexpression	GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN	FOXJ2 ARID1A ZC3H4 PLSCR1	1.11e-04	199	33	4	M3517
Coexpression	GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP	AMOTL2 LITAF PLSCR1 HGS	1.13e-04	200	33	4	M7754
Coexpression	GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP	LITAF LOXL1 HGS GPS2	1.13e-04	200	33	4	M5211
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	NCOA3 R3HDM2 ARID1B ARID1A ATXN2	2.47e-07	186	33	5	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	NCOA3 R3HDM2 ARID1B ARID1A ATXN2	2.47e-07	186	33	5	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	SEC31A TFG TJP1 VPS13C	1.35e-05	198	33	4	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 AMOTL2 ARID1A SS18 ZC3H4 TRPS1	1.82e-07	176	33	6	7499_DN
Drug	DOPAC	HGD CASC3 LOXL1 LOXL2 STATH	5.60e-07	112	33	5	CID000000547
Drug	actinorhodin	HGD NCOA3 DROSHA STATH	1.68e-06	60	33	4	CID005280985
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA2 AMOTL2 ARID1A ZC3H4 TRPS1	4.64e-06	172	33	5	1072_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	FOXJ2 NCOA2 ARID1A NDUFB8 ZC3H4	5.05e-06	175	33	5	6891_DN
Drug	trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA2 AMOTL2 ARID1A ZC3H4 TRPS1	5.19e-06	176	33	5	981_DN
Drug	trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA	NCOA2 AMOTL2 ARID1A ZC3H4 TRPS1	5.34e-06	177	33	5	873_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 AMOTL2 ARID1A ZC3H4 TRPS1	5.49e-06	178	33	5	1471_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 AMOTL2 ARID1A ZC3H4 TRPS1	5.95e-06	181	33	5	6951_DN
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	NCOA2 NCOA3 TSC22D2 ARID1A ZC3H4	6.62e-06	185	33	5	1114_DN
Drug	iprindole	BSN LOXL1 LOXL2	8.87e-06	28	33	3	CID000021722
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; HL60; HT_HG-U133A	NCOA2 NCOA3 TSC22D2 SS18 TRPS1	8.98e-06	197	33	5	2463_DN
Drug	amfonelic acid	BSN LOXL1 LOXL2	9.88e-06	29	33	3	CID000002137
Drug	amiguanidine	LOXL1 LOXL2	2.03e-05	5	33	2	CID000364439
Drug	Mctp	TJP1 LOXL1 LOXL2	2.08e-05	37	33	3	CID000129268
Drug	topa quinone	HGD LOXL1 LOXL2	2.64e-05	40	33	3	CID000123871
Drug	1-benzyl-2-methyl-5-methoxytryptamine	LOXL1 LOXL2	3.04e-05	6	33	2	CID000009925
Drug	butamben	NCOA2 NCOA3	3.04e-05	6	33	2	ctd:C004605
Drug	BU99006	LOXL1 LOXL2	3.04e-05	6	33	2	CID006603748
Drug	5-hydroxyisatin	LOXL1 LOXL2	3.04e-05	6	33	2	CID010352011
Drug	T 794	LOXL1 LOXL2	3.04e-05	6	33	2	CID003077680
Drug	NSD 2023	LOXL1 LOXL2	3.04e-05	6	33	2	CID000019831
Drug	1-PCPA	LOXL1 LOXL2	3.04e-05	6	33	2	CID000194548
Drug	N-cyclopropyl-5,6-dimethoxytryptamine	LOXL1 LOXL2	3.04e-05	6	33	2	CID000156277
Drug	N-cyclopropyl-6,7-dimethoxytryptamine	LOXL1 LOXL2	3.04e-05	6	33	2	CID000156278
Drug	N-cyclopropyl-alpha-methylbenzylamine	LOXL1 LOXL2	3.04e-05	6	33	2	CID000362778
Drug	bromfenacoum	ATXN2L BSN PDCD6IP ATXN2 TJP1 NDUFB8 HGS	3.16e-05	644	33	7	ctd:C013418
Drug	4-hydroxyphenylacetic acid	HGD LOXL1 LOXL2	3.29e-05	43	33	3	CID000000127
Drug	dimethylphenethylamine	LOXL1 LOXL2	4.26e-05	7	33	2	CID000025124
Drug	BU 224	LOXL1 LOXL2	4.26e-05	7	33	2	CID000002457
Drug	M 2113	LOXL1 LOXL2	4.26e-05	7	33	2	CID000072895
Drug	N-(2-aminoethyl)benzamide	LOXL1 LOXL2	4.26e-05	7	33	2	CID000423156
Drug	cimoxatone	LOXL1 LOXL2	4.26e-05	7	33	2	CID000052542
Drug	iproclozide	LOXL1 LOXL2	4.26e-05	7	33	2	CID000019063
Drug	brofaromine	LOXL1 LOXL2	4.26e-05	7	33	2	CID000044570
Drug	tetrahydroharmine	LOXL1 LOXL2	4.26e-05	7	33	2	CID000159809
Drug	4'-amino-MPTP	LOXL1 LOXL2	4.26e-05	7	33	2	CID000086263
Drug	4-methoxytranylcypromine	LOXL1 LOXL2	4.26e-05	7	33	2	CID003082143
Drug	1-Phenylcyclobutylamine	LOXL1 LOXL2	4.26e-05	7	33	2	CID000152214
Drug	JB 835	LOXL1 LOXL2	4.26e-05	7	33	2	CID000152988
Drug	1-benzylcyclopropylamine	LOXL1 LOXL2	4.26e-05	7	33	2	CID000152923
Drug	RS-2232	LOXL1 LOXL2	4.26e-05	7	33	2	CID000134882
Drug	SR 95191	LOXL1 LOXL2	4.26e-05	7	33	2	CID000072119
Drug	p-dimethylaminomethylbenzylamine	LOXL1 LOXL2	4.26e-05	7	33	2	CID000193714
Drug	MPTP-3-ol	LOXL1 LOXL2	4.26e-05	7	33	2	CID000100194
Drug	AC1O5VTH	LOXL1 LOXL2	5.67e-05	8	33	2	CID006441710
Drug	AC1Q6B1A	LOXL1 LOXL2	5.67e-05	8	33	2	CID000088562
Drug	4-chlorobenzylamine	LOXL1 LOXL2	5.67e-05	8	33	2	CID000066036
Drug	amezinium	LOXL1 LOXL2	5.67e-05	8	33	2	CID000071926
Drug	mebanazine	LOXL1 LOXL2	5.67e-05	8	33	2	CID000006179
Drug	mofegiline	LOXL1 LOXL2	5.67e-05	8	33	2	CID006437850
Drug	pyrazidol	LOXL1 LOXL2	5.67e-05	8	33	2	CID000068802
Drug	4-fluorotranylcypromine	LOXL1 LOXL2	5.67e-05	8	33	2	CID003082666
Drug	ranbezolid	LOXL1 LOXL2	5.67e-05	8	33	2	CID000496993
Drug	2-propyl-pentylamine	LOXL1 LOXL2	5.67e-05	8	33	2	CID000170419
Drug	Q 192	LOXL1 LOXL2	5.67e-05	8	33	2	CID000077317
Drug	benzylamine	HGD LOXL1 LOXL2	5.84e-05	52	33	3	CID000007504
Drug	benzalkonium	LOXL1 LOXL2 HGS STATH	6.06e-05	148	33	4	CID000007681
Drug	Lilly 51641	LOXL1 LOXL2	7.29e-05	9	33	2	CID000021485
Drug	3-amino-2-oxazolidinone	LOXL1 LOXL2	7.29e-05	9	33	2	CID000065725
Drug	toloxatone	LOXL1 LOXL2	7.29e-05	9	33	2	CID000034521
Drug	MDL 72392	LOXL1 LOXL2	7.29e-05	9	33	2	CID006439254
Drug	AC1L4KA6	LOXL1 LOXL2	7.29e-05	9	33	2	CID000158620
Drug	AC1L1BMC	LOXL1 LOXL2	7.29e-05	9	33	2	CID000001500
Drug	FLA 336	LOXL1 LOXL2	7.29e-05	9	33	2	CID000123706
Drug	RS-8359	LOXL1 LOXL2	7.29e-05	9	33	2	CID000164116
Drug	pinoline	LOXL1 LOXL2	7.29e-05	9	33	2	CID000001868
Drug	Ro 16-6491	LOXL1 LOXL2	7.29e-05	9	33	2	CID000004289
Drug	FLA 365	LOXL1 LOXL2	7.29e-05	9	33	2	CID000072776
Drug	J 508	LOXL1 LOXL2	7.29e-05	9	33	2	CID000155219
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 ARID1A ZC3H4 TRPS1	8.81e-05	163	33	4	7453_DN
Drug	EXP 561	LOXL1 LOXL2	9.10e-05	10	33	2	CID000027696
Drug	U-0521	LOXL1 LOXL2	9.10e-05	10	33	2	CID000021632
Drug	acetylcadaverine	LOXL1 LOXL2	9.10e-05	10	33	2	CID000189087
Drug	Monase	LOXL1 LOXL2	9.10e-05	10	33	2	CID000008366
Drug	3-dimethylamino-1-propyne	LOXL1 LOXL2	9.10e-05	10	33	2	CID000081643
Drug	thallium acetate	BSN STATH	9.10e-05	10	33	2	CID000011247
Drug	N-cyclopropylbenzylamine	LOXL1 LOXL2	9.10e-05	10	33	2	CID000025866
Drug	safrazine	LOXL1 LOXL2	9.10e-05	10	33	2	CID000034041
Drug	NmiQ	LOXL1 LOXL2	9.10e-05	10	33	2	CID000019850
Drug	NSC-169892	LOXL1 LOXL2	9.10e-05	10	33	2	CID000043479
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 ARID1A LOXL1 TRPS1	9.46e-05	166	33	4	7324_DN
Drug	Ph(2	TFG TJP1 DROSHA	9.90e-05	62	33	3	CID006432095
Drug	moclobemide	LOXL1 LOXL2 HGS	9.90e-05	62	33	3	CID000004235
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 ARID1A ZC3H4 TRPS1	9.90e-05	168	33	4	3868_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	NCOA2 ARID1A ZC3H4 TRPS1	1.04e-04	170	33	4	1050_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	NCOA2 ARID1A ZC3H4 TRPS1	1.06e-04	171	33	4	1000_DN
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	NCOA2 NCOA3 ATXN2 TRPS1	1.06e-04	171	33	4	7535_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 ARID1A ZC3H4 TRPS1	1.08e-04	172	33	4	3428_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 ARID1A ZC3H4 TRPS1	1.08e-04	172	33	4	6993_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 ARID1A ZC3H4 TRPS1	1.08e-04	172	33	4	2794_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 ARID1A ZC3H4 TRPS1	1.11e-04	173	33	4	5987_DN
Drug	befloxatone	LOXL1 LOXL2	1.11e-04	11	33	2	CID000060824
Drug	4-hydroxy-3-methoxyphenylglycol-piperazine	LOXL1 LOXL2	1.11e-04	11	33	2	CID002723890
Drug	NSC55260	LOXL1 LOXL2	1.11e-04	11	33	2	CID005356351
Drug	2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3	NCOA2 NCOA3	1.11e-04	11	33	2	ctd:C061137
Drug	Amiflamina	LOXL1 LOXL2	1.11e-04	11	33	2	CID000071221
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 ARID1A ZC3H4 TRPS1	1.13e-04	174	33	4	6579_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 ARID1A ZC3H4 TRPS1	1.13e-04	174	33	4	1659_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	NCOA2 ARID1A ZC3H4 TRPS1	1.13e-04	174	33	4	5945_DN
Disease	testosterone measurement	ATXN2L CASC3 R3HDM2 ARID1B TSC22D2 ARID1A SS18 ZC3H4 LITAF TRPS1	8.16e-07	1275	33	10	EFO_0004908
Disease	spinocerebellar ataxia type 2 (implicated_via_orthology)	ATXN2L ATXN2	1.21e-06	2	33	2	DOID:0050955 (implicated_via_orthology)
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B ARID1A	1.21e-05	5	33	2	C3281201
Disease	apolipoprotein A 1 measurement	NCOA2 R3HDM2 TSC22D2 ARID1A ATXN2 ZC3H4 TRPS1	3.51e-05	848	33	7	EFO_0004614
Disease	neuroblastoma (is_implicated_in)	ARID1B ARID1A	5.43e-05	10	33	2	DOID:769 (is_implicated_in)
Disease	HMG CoA reductase inhibitor use measurement	TSC22D2 ARID1A LITAF TRPS1	5.77e-05	189	33	4	EFO_0009932
Disease	glucose measurement	R3HDM2 BSN ATXN2 ZC3H4 VPS13C	6.09e-05	380	33	5	EFO_0004468
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ATXN2L ATXN2	7.95e-05	12	33	2	DOID:1441 (implicated_via_orthology)
Disease	apolipoprotein B measurement	R3HDM2 ARID1A ATXN2 LITAF GPS2 TRPS1	8.31e-05	663	33	6	EFO_0004615
Disease	Coffin-Siris syndrome	ARID1B ARID1A	9.39e-05	13	33	2	C0265338
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	R3HDM2 TSC22D2 ARID1A TRPS1	1.11e-04	224	33	4	EFO_0004530, EFO_0008317
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	R3HDM2 ARID1A ATXN2 TRPS1	1.11e-04	224	33	4	EFO_0004574, EFO_0008317
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	R3HDM2 ARID1A ATXN2 TRPS1	1.13e-04	225	33	4	EFO_0008317, EFO_0010351
Disease	non-high density lipoprotein cholesterol measurement	R3HDM2 ARID1A ATXN2 ZC3H4 LITAF TRPS1	1.24e-04	713	33	6	EFO_0005689
Disease	sexual dimorphism measurement	ATXN2L BSN ARID1A ZC3H4 LOXL1 LOXL2 TRPS1	1.85e-04	1106	33	7	EFO_0021796
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	R3HDM2 ARID1A TRPS1	2.34e-04	107	33	3	EFO_0004614, EFO_0004615
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	R3HDM2 TSC22D2 ATXN2 TRPS1	2.48e-04	276	33	4	EFO_0004612, EFO_0020943
Disease	Breast Carcinoma	NCOA2 NCOA3 ARID1B ARID1A LOXL2	3.08e-04	538	33	5	C0678222
Disease	serum alanine aminotransferase measurement	ATXN2L TSC22D2 ARID1A ATXN2 ZC3H4 TRPS1	3.60e-04	869	33	6	EFO_0004735
Disease	neuroticism measurement, cognitive function measurement	ATXN2L R3HDM2 TSC22D2 ARID1A TRPS1	3.88e-04	566	33	5	EFO_0007660, EFO_0008354
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	TSC22D2 ARID1A ATXN2 TRPS1	3.94e-04	312	33	4	EFO_0004612, EFO_0010351
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	TSC22D2 ARID1A ATXN2 TRPS1	4.08e-04	315	33	4	EFO_0004574, EFO_0004612
Disease	Bilateral Wilms Tumor	ARID1A DROSHA	4.83e-04	29	33	2	C2930471
Disease	lung non-small cell carcinoma (is_implicated_in)	NCOA2 ARID1B ARID1A	5.03e-04	139	33	3	DOID:3908 (is_implicated_in)
Disease	grip strength measurement	ATXN2L ZC3H4 LOXL1 TRPS1	6.07e-04	350	33	4	EFO_0006941
Disease	glaucoma	TSC22D2 ATXN2 LOXL1	6.78e-04	154	33	3	MONDO_0005041
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	ATXN2L TSC22D2 ZC3H4 TRPS1	7.03e-04	364	33	4	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	Nephroblastoma	ARID1A DROSHA	7.46e-04	36	33	2	C0027708
Disease	alcohol consumption measurement, high density lipoprotein cholesterol measurement	R3HDM2 ARID1A TRPS1	7.85e-04	162	33	3	EFO_0004612, EFO_0007878
Disease	sex interaction measurement, Crohn's disease	BSN LITAF	7.88e-04	37	33	2	EFO_0000384, EFO_0008343
Disease	hematocrit	R3HDM2 ARID1B BSN ATXN2 ZC3H4 TRPS1	7.99e-04	1011	33	6	EFO_0004348
Disease	alcohol drinking, high density lipoprotein cholesterol measurement	R3HDM2 ARID1A TRPS1	8.72e-04	168	33	3	EFO_0004329, EFO_0004612
Disease	anthropometric measurement	BSN ATXN2 LOXL1	8.72e-04	168	33	3	EFO_0004302
Disease	reticulocyte count	TSC22D2 AMOTL2 BSN ATXN2 ZC3H4 TRPS1	9.49e-04	1045	33	6	EFO_0007986
Disease	Neoplasm of uncertain or unknown behavior of breast	ARID1B ARID1A	9.68e-04	41	33	2	C0496956
Disease	Breast adenocarcinoma	ARID1B ARID1A	9.68e-04	41	33	2	C0858252
Disease	reticulocyte measurement	TSC22D2 AMOTL2 BSN ATXN2 ZC3H4 TRPS1	9.87e-04	1053	33	6	EFO_0010700
Disease	colorectal cancer, endometrial neoplasm	ATXN2 LITAF	1.02e-03	42	33	2	EFO_0004230, MONDO_0005575
Disease	spleen volume	ATXN2 TJP1	1.06e-03	43	33	2	EFO_0600047
Disease	coffee consumption measurement, tea consumption measurement	ATXN2 ZC3H4	1.11e-03	44	33	2	EFO_0006781, EFO_0010091

Protein segments in the cluster

Peptide	Gene	Start	Entry
QYQYLQQSQEHPPPP	AMOTL2	261	Q9Y2J4
FPAVQYLSQPQPQPY	GPS2	216	Q13227
CQQGQQPYYSQQPQP	ARID1B	676	Q8NFD5
SYIPYNPQQFPGQPA	ATXN2L	786	Q8WWM7
QPPQQIQVSYYPPGQ	R3HDM2	511	Q9Y2K5
YPPGQYPNSNQQYRP	R3HDM2	521	Q9Y2K5
YYTQPAPIPNNNPIT	LITAF	61	Q99732
YNQQSPHPQQQQPPY	ARID1A	471	O14497
QSQPPYSQPQAQSPY	ARID1A	546	O14497
TQYVAYSPQQFPNQP	ATXN2	1036	Q99700
TYRQQPSYPQQFPYP	LOXL1	166	Q08397
YFQQPAPEYHQPQAP	LOXL2	36	Q9Y4K0
FQQPRFQPPAPQYSA	BSN	3051	Q9UPA5
QPSYPFPQPPQQSYY	PDCD6IP	851	Q8WUM4
FPVPNQPVYNQPVYN	PLSCR1	61	O15162
QPVYNQPVYNQPVGA	PLSCR1	66	O15162
NYYMYQQQQPPPPQQ	FOXJ2	286	Q9P0K8
PVYQPVGPKQYPYNN	NDUFB8	151	O95169
PPQALNAYYLPNKNQ	ECEL1	566	O95672
YYNPAQQQVQPKPSP	CASC3	666	O15234
NPQVPDYPPNYILFL	SNRPB2	141	P08579
PEGQNNPQVCPYNLY	HGD	26	Q93099
LLHPQQPPVQYQYEP	DROSHA	41	Q9NRR4
QPLYPQPYQPQYQQY	STATH	46	P02808
AQQPQQFAYPQPQIP	TSC22D2	351	O75157
LPVYPHQQNYQPSQY	TAB3	266	Q8N5C8
MPQAPPQQFPYQPNY	NCOA3	1301	Q9Y6Q9
IPQANAQQFPFPPNY	NCOA2	1291	Q15596
NPCQNYVPYPTFNLP	TRPS1	1136	Q9UHF7
LPAQPPQQYQASNYP	TFG	311	Q92734
PQQGYPPQQQQYPGQ	SS18	341	Q15532
PPQQPYIAGQQPMYQ	HGS	726	O14964
GNIPPNYQYIFQPIS	VPS13C	286	Q709C8
PPIPPAQNFYENFYQ	ZC3H4	686	Q9UPT8
ENQTYPPYSPQAQPQ	TJP1	891	Q07157
VQTQQYYPHGENPPP	SEC31A	826	O94979